rs144635565
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BA1BP4_Strong
This summary comes from the ClinGen Evidence Repository: The NM_001034853.2(RPGR):c.1367A>G (p.Gln456Arg) variant is a missense variant encoding the substitution of Glutamine with Arginine at amino acid 456. This variant is present in gnomAD v.4.1.0 at a frequency of 0.01145 among hemizygous individuals, with 4533 variant alleles / 395737 hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). This variant has been reported in three probands with an alternate molecular basis for the disease (PMIDs: 18552978, 22334370, 11992260). However, the BP5 code is considered not applicable for RPGR-related retinopathy. The computational predictor REVEL gives a score of 0.016, which is below the ClinGen X-linked IRD VCEP threshold of < 0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.08, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4_strong). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BA1 and BP4_strong. (VCEP specifications version 1.0.0; date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA146033/MONDO:0100437/106
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RPGR | ENST00000645032.1 | c.1367A>G | p.Gln456Arg | missense_variant | Exon 11 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
| ENSG00000250349 | ENST00000465127.1 | c.172-368790T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.00788 AC: 869AN: 110303Hom.: 2 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.00831 AC: 1524AN: 183345 AF XY: 0.00796 show subpopulations
GnomAD4 exome AF: 0.0124 AC: 13585AN: 1097770Hom.: 71 Cov.: 30 AF XY: 0.0119 AC XY: 4309AN XY: 363160 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00787 AC: 869AN: 110357Hom.: 2 Cov.: 22 AF XY: 0.00688 AC XY: 224AN XY: 32577 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:5
- -
- -
- -
See Variant Classification Assertion Criteria. -
- -
not specified Benign:4
- -
- -
- -
p.Gln456Arg in exon 11 of RPGR: This variant is not expected to have clinical significance because it has been identified in 1.1% (71/6728) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs144635565). -
Primary ciliary dyskinesia Benign:2
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Retinal dystrophy Uncertain:1
- -
RPGR-related retinopathy Benign:1
The NM_001034853.2(RPGR):c.1367A>G (p.Gln456Arg) variant is a missense variant encoding the substitution of Glutamine with Arginine at amino acid 456. This variant is present in gnomAD v.4.1.0 at a frequency of 0.01145 among hemizygous individuals, with 4533 variant alleles / 395737 hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). This variant has been reported in three probands with an alternate molecular basis for the disease (PMIDs: 18552978, 22334370, 11992260). However, the BP5 code is considered not applicable for RPGR-related retinopathy. The computational predictor REVEL gives a score of 0.016, which is below the ClinGen X-linked IRD VCEP threshold of < 0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.08, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4_strong). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BA1 and BP4_strong. (VCEP specifications version 1.0.0; date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at